PATH-Pain: A Primary Care-Based Psychosocial Intervention To Improve Cognitive and Depression Outcomes in Older Adults with MCI and Early Stage AD
PATH-Pain:一种基于初级保健的心理社会干预措施,可改善患有 MCI 和早期 AD 的老年人的认知和抑郁结果
基本信息
- 批准号:10682594
- 负责人:
- 金额:$ 68.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-15 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcuteAddressAffectiveAftercareAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAttentionBehavioralCalendarCaregiversCertificationClinicalCognitionCognitiveCognitive deficitsDataDementiaElderlyEmotionalEmotionsFamily memberFeeling hopelessFriendsHabitsHealthImpaired cognitionIndividualInternal MedicineInterventionInterviewLocationMeasuresMediatingMedicineMental DepressionMental HealthMontgomery and Asberg depression rating scaleNeurologyNeuropsychologyOutcomePainPain intensityPain managementPamphletsParticipantPatientsPersonsPharmaceutical PreparationsPopulationPrimary CareProbabilityProblem SolvingProceduresPsychiatryPublic HealthQuestionnairesRandomizedReactionRecommendationResearch AssistantResearch PersonnelResourcesRiskSeveritiesSiteStressStructureTabletsTechniquesTelephoneTestingTimeacceptability and feasibilityattentional controlchronic depressionchronic painchronic pain patientclinically significantcognitive functioncognitive testingcomorbid depressioncomorbiditydementia riskdepressive symptomsdistractionemotion dysregulationemotion regulationenvironmental adaptationexperiencefollow-upfunctional outcomesimprovedinnovationmembermild cognitive impairmentnovelpain outcomepain reductionpain-related disabilityperceived stresspositive emotional statepower analysisprimary outcomepsychosocialrecruitsatisfactionsecondary outcomesexstress reductionsustained attentiontelephone sessiontherapy designtooltreatment as usualtreatment effectusual care arm
项目摘要
This MPI R01 combines the expertise of the Departments of Psychiatry, Neurology, and Internal Medicine at Weill Cornell Medicine to address MCI (mild cognitive impairment) and early stage AD/ADRD in patients with comorbid chronic pain and depression. We propose to test whether Problem Adaptation Therapy for Pain (PATH-Pain), a novel primary-care based psychosocial intervention designed to reduce stress in MCI and early stage AD/ADRD patients with comorbid depression and pain, has better cognitive, affective, and functional outcomes than Attention Control Usual Care.
PATH-Pain is an easy-to-administer psychosocial intervention designed to improve emotion regulation and reduce stress in older adults with MCI or early stage AD/ADRD, chronic pain, and depression. To reduce stress, PATH-Pain aims to: a) reduce negative emotions associated with pain and pain-related disability; b) reduce negative emotions that interfere with pain treatment (e.g., hopelessness, helplessness); c) increase positive emotions and increase engagement in pleasurable activities; d) help patients identify addressable problems in their lives and try to find the best possible solution to these problems; e) reduce interpersonal tension between patients and family members, caregivers, and friends; and f) shift attention during experiences of pain to reduce pain intensity. To achieve these aims, PATH-Pain employs emotion regulation, problem solving, and behavioral activation techniques. In our preliminary study, PATH-Pain participants showed high acceptability and treatment satisfaction with the intervention.
Based on our power analysis, we will randomize 100 older adults (60 years and older) with MCI or early stage dementia (probable or possible Alzheimer’s Disease), comorbid depression, and chronic pain to 8 weekly in-office sessions and 6 monthly phone (3 individual and 3 group) sessions of PATH-Pain vs. Attention Control Usual Care in 4 primary care sites. The Attention Control Usual Care arm consists of Usual Care, a pamphlet on pain and depression, and a structured interview of the same duration as each PATH-Pain session. The structured interview aims to control for attention and time, and will consist of general questions regarding health habits and other non-medical topics unrelated to cognitive impairment, pain, and depression. The investigators have shown evidence of feasibility of recruitment, retention, and assessment procedures for the proposed study. Assessments will be performed at baseline, and weeks 5 (no cognitive outcomes), 9, 24 (no cognitive outcomes), 36, and 52 by research assistants unaware of the study hypotheses and the participants’ randomization status. PATH-Pain will be administered by certified mental health workers and the Attention-Control sessions will be administered by a non-clinician team member experienced in structured interviews.
该MPI R 01结合了威尔康奈尔大学医学院精神病学,神经病学和内科的专业知识,以解决MCI(轻度认知障碍)和早期AD/ADRD共病慢性疼痛和抑郁症患者的问题。我们建议测试疼痛问题适应疗法(PATH-Pain),一种新的基于初级保健的心理社会干预,旨在减少MCI和早期AD/ADRD患者抑郁和疼痛共病的压力,是否比注意力控制护理具有更好的认知,情感和功能结果。
PATH-Pain是一种易于管理的心理社会干预,旨在改善MCI或早期AD/ADRD、慢性疼痛和抑郁症老年人的情绪调节并减轻压力。为了减轻压力,PATH-Pain旨在:a)减少与疼痛和疼痛相关残疾相关的负面情绪; B)减少干扰疼痛治疗的负面情绪(例如,绝望,无助); c)增加积极的情绪,增加对愉快活动的参与; d)帮助患者识别他们生活中可解决的问题,并试图找到解决这些问题的最佳方案; e)减少患者与家庭成员,照顾者和朋友之间的人际紧张关系; f)在疼痛体验期间转移注意力,以减轻疼痛强度。为了实现这些目标,PATH-Pain采用情绪调节,解决问题和行为激活技术。在我们的初步研究中,PATH-Pain参与者对干预表现出较高的可接受性和治疗满意度。
根据我们的功效分析,我们将100名患有MCI或早期痴呆(可能或可能的阿尔茨海默病)、共病抑郁症和慢性疼痛的老年人(60岁及以上)随机分配至4个初级保健中心的8个每周一次的办公室会议和6个每月一次的电话会议(3个人和3个小组)。注意力控制的心理护理组包括心理护理、关于疼痛和抑郁的小册子以及与每次病理疼痛会议相同持续时间的结构化访谈。结构化访谈旨在控制注意力和时间,并将包括有关健康习惯的一般问题和与认知障碍,疼痛和抑郁无关的其他非医学主题。研究者已经证明了拟定研究的招募、保留和评估程序的可行性。将在基线和第5周(无认知结局)、第9周、第24周(无认知结局)、第36周和第52周由不了解研究假设和受试者随机化状态的研究助理进行评估。路径-疼痛将由经认证的精神卫生工作者进行,注意力控制课程将由在结构化访谈中有经验的非临床医生团队成员进行。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DIMITRIS N KIOSSES其他文献
DIMITRIS N KIOSSES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DIMITRIS N KIOSSES', 18)}}的其他基金
A Mobile Intervention for Suicide Prevention For Middle-aged And Older Adults After a Suicide-Related Hospitalization
中老年人因自杀住院后预防自杀的移动干预
- 批准号:
10559578 - 财政年份:2022
- 资助金额:
$ 68.54万 - 项目类别:
A Mobile Intervention for Suicide Prevention For Middle-aged And Older Adults After a Suicide-Related Hospitalization
中老年人因自杀住院后预防自杀的移动干预
- 批准号:
10356268 - 财政年份:2022
- 资助金额:
$ 68.54万 - 项目类别:
PATH-Pain: A Primary Care-Based Psychosocial Intervention To Improve Cognitive and Depression Outcomes in Older Adults with MCI and Early Stage AD
PATH-Pain:一种基于初级保健的心理社会干预措施,可改善患有 MCI 和早期 AD 的老年人的认知和抑郁结果
- 批准号:
10297969 - 财政年份:2021
- 资助金额:
$ 68.54万 - 项目类别:
PATH-Pain: A Primary Care-Based Psychosocial Intervention To Improve Cognitive and Depression Outcomes in Older Adults with MCI and Early Stage AD
PATH-Pain:一种基于初级保健的心理社会干预措施,可改善患有 MCI 和早期 AD 的老年人的认知和抑郁结果
- 批准号:
10461920 - 财政年份:2021
- 资助金额:
$ 68.54万 - 项目类别:
A Novel Cognitive Reappraisal Intervention for Suicide Prevention
预防自杀的新型认知重评干预措施
- 批准号:
10005464 - 财政年份:2016
- 资助金额:
$ 68.54万 - 项目类别:
Problem Adaptation Therapy for Mild Cognitive Impairment with Depression
轻度认知障碍抑郁症的问题适应疗法
- 批准号:
9335774 - 财政年份:2016
- 资助金额:
$ 68.54万 - 项目类别:
A Novel Cognitive Reappraisal Intervention for Suicide Prevention
预防自杀的新型认知重评干预措施
- 批准号:
10478388 - 财政年份:2016
- 资助金额:
$ 68.54万 - 项目类别:
A Novel Cognitive Reappraisal Intervention for Suicide Prevention
预防自杀的新型认知重评干预措施
- 批准号:
9164519 - 财政年份:2016
- 资助金额:
$ 68.54万 - 项目类别:
Problem Adaptation Therapy for Mild Cognitive Impairment with Depression
轻度认知障碍抑郁症的问题适应疗法
- 批准号:
9196618 - 财政年份:2016
- 资助金额:
$ 68.54万 - 项目类别:
Home-Delivered Intervention for Depressed, Cognitively Impaired Elders
为抑郁、认知障碍的老年人提供上门干预
- 批准号:
8793812 - 财政年份:2011
- 资助金额:
$ 68.54万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 68.54万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 68.54万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 68.54万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 68.54万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 68.54万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 68.54万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 68.54万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 68.54万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 68.54万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 68.54万 - 项目类别:
Operating Grants